{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:31:09Z","timestamp":1761489069554},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2013,1,23]],"date-time":"2013-01-23T00:00:00Z","timestamp":1358899200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0054190","type":"journal-article","created":{"date-parts":[[2013,1,23]],"date-time":"2013-01-23T21:57:10Z","timestamp":1358978230000},"page":"e54190","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":27,"title":["Antibiotic Rotation for Febrile Neutropenic Patients with Hematological Malignancies: Clinical Significance of Antibiotic Heterogeneity"],"prefix":"10.1371","volume":"8","author":[{"given":"Yong","family":"Chong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Shimoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Yakushiji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshikiyo","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiro","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiko","family":"Kamimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Shimono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Akashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,1,23]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1086\/339215","article-title":"2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer","volume":"34","author":"WT Hughes","year":"2002","journal-title":"Clin Infect Dis"},{"key":"ref2","first-page":"S105","article-title":"Antimicrobial therapy of unexplained fever in neutropenic patients\u2013guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeitsgemeinschaft Supportivmassnahmen in der Onkologie (ASO) of the Deutsche Krebsgesellschaft (DKG-German Cancer Society)","volume":"82 Suppl 2","author":"H Link","year":"2003","journal-title":"Ann Hematol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1016\/j.ijid.2010.01.004","article-title":"Cefepime-resistant Gram-negative bacteremia in febrile neutropenic patients with hematological malignancies","volume":"14 Suppl 3","author":"Y Chong","year":"2010","journal-title":"Int J Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1097\/00003246-200010000-00014","article-title":"Inadequate treatment of nosocomial infections is associated with certain empiric antibiotic choices","volume":"28","author":"MH Kollef","year":"2000","journal-title":"Crit Care Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1097\/00003246-200106000-00001","article-title":"Impact of a rotating empiric antibiotic schedule on infectious mortality in an intensive care unit","volume":"29","author":"DP Raymond","year":"2001","journal-title":"Crit Care Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1097\/01.CCM.0000069729.06687.DE","article-title":"Strategy of antibiotic rotation: long-term effect on incidence and susceptibilities of Gram-negative bacilli responsible for ventilator-associated pneumonia","volume":"31","author":"D Gruson","year":"2003","journal-title":"Crit Care Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1089\/sur.2005.6.41","article-title":"Influence of antibiotic therapy on mortality of critical surgical illness caused or complicated by infection","volume":"6","author":"PS Barie","year":"2005","journal-title":"Surg Infect (Larchmt)"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/TA.0b013e318120595e","article-title":"Implementation of antibiotic rotation protocol improves antibiotic susceptibility profile in a surgical intensive care unit","volume":"63","author":"KM Bennett","year":"2007","journal-title":"J Trauma"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s10096-010-0964-5","article-title":"Rotation of antimicrobial therapy in the intensive care unit: impact on incidence of ventilator-associated pneumonia caused by antibiotic-resistant Gram-negative bacteria","volume":"29","author":"E Raineri","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1097\/01.CCM.0000147685.79487.28","article-title":"Cycling empirical antimicrobial agents to prevent emergence of antimicrobial-resistant Gram-negative bacteria among intensive care unit patients","volume":"32","author":"DK Warren","year":"2004","journal-title":"Crit Care Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1089\/sur.2005.6.223","article-title":"Nature of gram-negative rod antibiotic resistance during antibiotic rotation","volume":"6","author":"HL Evans","year":"2005","journal-title":"Surg Infect (Larchmt)"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/jac\/dkh482","article-title":"Antibiotic cycling or rotation: a systematic review of the evidence of efficacy","volume":"55","author":"EM Brown","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1086\/504484","article-title":"Is antibiotic cycling the answer to preventing the emergence of bacterial resistance in the intensive care unit?","volume":"43 Suppl 2","author":"MH Kollef","year":"2006","journal-title":"Clin Infect Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1749-6632.2010.05867.x","article-title":"Antibiotic heterogeneity: from concept to practice","volume":"1213","author":"AM Bal","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jac\/43.2.261","article-title":"The control of hyperendemic glycopeptide-resistant Enterococcus spp. on a haematology unit by changing antibiotic usage","volume":"43","author":"SJ Bradley","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1086\/503166","article-title":"A pilot study of antibiotic cycling in a hematology-oncology unit","volume":"21","author":"EA Dominguez","year":"2000","journal-title":"Infect Control Hosp Epidemiol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/sj.bmt.1705591","article-title":"The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit","volume":"39","author":"M Craig","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/sj.bmt.1705704","article-title":"Antibiotic cycling to decrease bacterial antibiotic resistance: a 5-year experience on a bone marrow transplant unit","volume":"40","author":"J Cadena","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10096-011-1290-2","article-title":"Clinical impact of cycling the administration of antibiotics for febrile neutropenia in Japanese patients with hematological malignancy","volume":"31","author":"S Hashino","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1086\/383048","article-title":"Changes in the etiology of bacteremia in febrile neutropenic patients and the susceptibilities of the currently isolated pathogens","volume":"39 Suppl 1","author":"R Ramphal","year":"2004","journal-title":"Clin Infect Dis"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"e277","DOI":"10.1016\/j.ijid.2010.12.010","article-title":"Clinical impact of fluoroquinolone prophylaxis in neutropenic patients with hematological malignancies","volume":"15","author":"Y Chong","year":"2011","journal-title":"Int J Infect Dis"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america","volume":"52","author":"AG Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"13285","DOI":"10.1073\/pnas.0402298101","article-title":"Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals","volume":"101","author":"CT Bergstrom","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref24","unstructured":"National Committee for Clinical Laboratory Standards (2004) Performance Standards for Antimicrobial Susceptibility Testing. 14th Informational Supplement. Wayne, Pennsylvania: NCCLS"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1086\/321807","article-title":"Acquisition of vancomycin-resistant enterococci during scheduled antimicrobial rotation in an intensive care unit","volume":"33","author":"LA Puzniak","year":"2001","journal-title":"Clin Infect Dis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"S164","DOI":"10.1086\/500663","article-title":"Extended-spectrum beta-lactamases and clinical outcomes: current data","volume":"42 Suppl 4","author":"R Ramphal","year":"2006","journal-title":"Clin Infect Dis"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/jama.280.14.1233","article-title":"Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella","volume":"280","author":"JJ Rahal","year":"1998","journal-title":"JAMA"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1086\/502304","article-title":"Reduced use of third-generation cephalosporins decreases the acquisition of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae","volume":"25","author":"SO Lee","year":"2004","journal-title":"Infect Control Hosp Epidemiol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s10156-006-0452-0","article-title":"Impact of ceftazidime restriction on gram-negative bacterial resistance in an intensive care unit","volume":"12","author":"N Brahmi","year":"2006","journal-title":"J Infect Chemother"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1093\/jac\/dkn164","article-title":"Control of extended-spectrum {beta}-lactamase-producing Klebsiella pneumoniae using a computer-assisted management program to restrict third-generation cephalosporin use","volume":"62","author":"JY Kim","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1086\/508877","article-title":"Bacteremia due to extended-spectrum beta -lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge","volume":"43","author":"J Rodriguez-Bano","year":"2006","journal-title":"Clin Infect Dis"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1086\/649537","article-title":"Community-onset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis","volume":"50","author":"J Rodriguez-Bano","year":"2010","journal-title":"Clin Infect Dis"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/jac\/dkp411","article-title":"Bacteraemia due to extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome","volume":"65","author":"C Gudiol","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jhin.2009.11.022","article-title":"Impact of a hospital-wide programme of heterogeneous antibiotic use on the development of antibiotic-resistant Gram-negative bacteria","volume":"75","author":"Y Takesue","year":"2010","journal-title":"J Hosp Infect"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0054190","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T23:24:33Z","timestamp":1540337073000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0054190"}},"subtitle":[],"editor":[{"given":"Omar","family":"Sued","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,1,23]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,1,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0054190","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,23]]}}}